The International AIDS Society (IAS) wrote a letter to the Chair of the Commission on Narcotics Drugs (CND) to express concern about the absence of language on harm reduction in the draft outcome documents to be adopted by the 52nd session of the Commission on Narcotic Drugs in March 2009.
The International AIDS Society is world’s leading independent association of HIV professionals with over 11,000 members from 183 countries; and the custodian of the International AIDS Conference to be held in Vienna in 2010.
UNDCPs 1998 plan to eradicate the cultivation of both coca and opium poppy by the year 2008 was a rare opportunity to re-think current drugs efforts. Member states were asked to endorse a plan, known as SCOPE, for the eradication of drugs-linked crops by 2008. Is SCOPE viable? And what impact would it have on poor farmers who grow drugs-linked crops to survive?
The International Drug Policy Consortium (IDPC) – of which TNI is a member – published a second version of its Advocacy Guide that provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations. It describes the latest situation on the planning for the review, and sets out the IDPC position on which issues need to be addressed in the review, and how these issues may be tackled in order to achieve a constructive outcome.
The 50th Commission on Narcotic Drugs (CND), held in Vienna from 12-16 March 2007 was the last such event before the watershed year of 2008, when the international community will review progress against the objectives set at the General Assembly Special Session on Drugs (UNGASS), held in New York in 1998. The key decision that had to be taken at the 2007 CND was the timing and procedure for the UNGASS review.
Conflicting views and policies within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic; efforts in which harm reduction practices like needle exchange and substitution treatment play a pivotal role.
TNI co-signed a letter that was sent to the Dutch Prime Minister and relevant parliamentary commissions, stressing the need for an active Dutch involvement in the UNGASS review process and specifically to use the moment to open the discussion about the UN conventions that are an obstacle to further developments in Dutch cannabis policy.
The 50th Commission on Narcotic Drugs (CND) was the last such event before the watershed year of 2008, when the international community will review progress against the objectives set at the General Assembly Special Session on Drugs (UNGASS), held in New York in 1998. This CND was notable for a significant improvement in civil society involvement in the proceedings – there were a record 81 civil society delegates and NGO representatives included in government delegations. On the other hand, there were repeated moves by some country delegations to marginalise NGO involvement. The global consultation with NGOs to feed in to the UNGASS review process as formally launched.
At the 49th Session of the Commission on Narcotic Drugs (CND), held in Vienna in March 2006, a draft resolution was tabled by the European Union (EU) to guide the process of evaluation of the implementation of political declaration and action plans of the 1998 UN General Assembly Special Session (UNGASS) in 2008. This briefing describes the fortunes of the resolution and its proposals to strengthen the upcoming UNGASS evaluation process. It explores how the resolution’s aims for more objective and transparent assessment were ultimately watered down. This was a result not only of opposition from states wary of transparency, objectivity and a possible re-evaluation of some current UN policies, but also the EU’s own approach to operating at the CND.
Martin Jelsma analysed the 2003 UNGASS mid-term review and drew some important conclusions for the 10-year review in 2008: "Alliances have to be constructed rooted in pragmatic approaches and in solidarity with the victims of this War on Drugs on both sides of the spectrum, be they in the North or in the South, consumers or producers. The concepts of ‘co-responsibility’ and a ‘balanced approach’ between demand and supply sides have to be redefined. Only if such a coalition of like-minded countries could be brought together, and act in a coordinated manner to explore more pragmatica drug policies for both the demand and the supply sides, the UN level might become a useful forum. Only then, a stronger political alliance can enforce a more open-minded debate about current anti-drug strategies and challenge the US hegemony and discourse in this field."
In a first analysis of the outcomes of the 2003 UNGASS mid-term review in April 2003, TNI concluded that the outcomes were very disappointing. The absence of significant progress over the past five years had not led to self-reflection and evaluation. The goals and targets of the UNGASS were simply re-affirmed. Most countries concentrated on a stock taking halfway of the implemented measures, without an honest analysis of the impact. The result is a distorted picture of virtual progress in order to justify to stay on the same course. The illusion is kept alive that reality will somehow fall into line with wishful thinking.
The "international community" presented an apparent unanimity in its endorsement of prohibitive drug control at the United Nations General Assembly Special Session (UNGASS) on drugs in 1998. The reality is that there is a longstanding conflict within the UN system between nations wanting to maintain the prohibition regime and those hoping for a more pragmatic approach.
Meetings of the Commission on Narcotic Drugs (CND) are no forum for debate and change. The author, a former senior officer of the United Nations International Drug Control Programme (UNDCP), shows how CND meetings are manipulated in the interests of 17 developed countries that largely fund UNDCP – the CND’s ‘civil service’. However, these major donors are not united on policy or on how to apply the UN drug Conventions, so CND decisions reflect the lowest level of disagreement, with major splits on policy ignored.
Alternative Development programmes, aimed at encouraging peasants to switch from growing illicit drugs-related crops, play an important role in UN drug control strategies. The record of success, however, is a questionable one. Decades of efforts to reduce global drug supply using a combination of developmental and repressive means, managed to shift production from one country to another, but have failed in terms of global impact.
By 1998, when the United Nations convened a special General Assembly on drugs, there was already overwhelming evidence that the current approach to global drugs control had failed miserably, given the continuing rise in consumption and production. However, the evidence was ignored and no evaluation of what was wrong with current drug policy took place. Instead, as a New York Times editorial noted, unrealistic pledges were recycled, this time aiming at eliminating all drug production by the year 2008. In mid-April this year, the mid-term review of the goals and targets set by the special session on drugs is to take place in Vienna.
Allow countries and regions more space for policy reform using and stretching the margins of the conventions. Strengthen alliances of like-minded nations to support one another and effectively coordinate efforts at the UN level through informal consultations and strategy meetings. Any crack in the global prohibition regime would not plunge the world into chaos immediately. We should not press for a new global straitjacket but for a model that respects cultural differences. We have to open up the debate about the wisdom of the conventions as they stand.